Purpose: To compare elimination of methicillin-resistant Staphylococcus aureus (MRSA) by exposure of blue light alone and with riboflavin. Methods: A reference strain of MRSA was cultured and diluted in PBS with and without riboflavin (0.01%). Fifteen microlitre was added on a microscope slide, creating a fluid layer with a thickness of around 400 microns. Both of the bacterial suspensions were exposed to blue light, and the effect between exposure with and without riboflavin was compared. Evaluation involved two different wavelengths (412 and 450 nm) of blue light with a lower (5.4 J/cm 2 ) and higher dose (approximately 28.5 J/cm 2 ). The effect of 412 nm light was also evaluated for a thicker fluid layer (1.17 mm). After exposure, colony-forming units (CFUs) were determined for each solution. All measurements were repeated eight times. Results: The reductions in bacteria were similar for both wavelengths. With riboflavin, a statistically significant elimination was observed for both 412 and 450 nm (p < 0.001). At both dosages, the mean reduction was more pronounced with the presence of riboflavin than without it. Using the higher dose, CFU reduction was 99% and 98%, respectively, for 412 and 450 nm light. The bactericidal efficacy was high also in the deeper fluid layer (93%, higher dose). Conclusion: Riboflavin enhanced the antibacterial effect on the exposed MRSA strain of blue light for both 412 and 450 nm blue light. This indicates that blue light could be considered for possible implementation in deep corneal infections.
Introduction
Riboflavin photoactivation can be mediated by ultraviolet light and is in clinical practice today through corneal collagen cross-linking (CXL), which is currently the only treatment aimed at arresting the progression of keratoconus, pellucid marginal degeneration (PMD), and post-LASIK ectasia (Mastropasqua 2015; Sorkin & Varssano 2014) . The use of same method in keratitis and corneal melting has been explored in multiple reports, indicating that it may be possible to apply this mode of therapy in corneal infections (Chan et al. 2015; Tabibian et al. 2016; Papaioannou et al. 2016) . Multiple experimental articles have supported the hypothesis by demonstrating the antimicrobial effect through UVAmediated (365 nm) riboflavin photoactivation (Martins et al. 2008; Schrier et al. 2009; Makdoumi & Backman 2016) . As it is possible to generate photo-oxidative stress by numerous photo-sensitizers or chromophores, the term PACK-CXL was created (Hafezi & Randleman 2014) .
The scientific support leading to implementing riboflavin excitation in corneal infections is based on the research made in transfusion medicine, and several studies have demonstrated that it is possible to generate extensive pathogenic elimination through ultraviolet light excitation of riboflavin. By exploiting this phenomenon, the device named Mirasol Ò PRT system, Terumo BCT, Inc., is used today to increase safety in transfusions, by eliminating possible microbial contamination (Marschner & Goodrich 2011; Kaiser-Guignard et al. 2014) .
As riboflavin has an absorption spectrum that also has peaks in the visible light spectrum, the possibility to activate the molecule through exposure of blue light (405-450 nm) has been explored. The combination has been proposed for clinical use in several areas of medicine, such as cross-linking of dentin in dentistry (Fawzy et al. 2012) , and in ophthalmology, to strengthen scleral tissue (Zhang et al. 2015; Iseli et al. 2016 ) but also to crosslink silk fibroin for ocular prostheses (Applegate et al. 2016) .
Blue light has lower energy than UVA and causes less direct damage to cellular components, including DNA. During CXL, the cornea imbibed with riboflavin absorbs most of the UVA at the surface limiting the antibacterial effect at deeper levels of the cornea, which may explain a lower efficacy of PACK-CXL, especially in deep infections. As longer wavelengths have greater tissue penetrance, more advanced infections could in theory be treated using blue light, and perhaps combined with riboflavin most of the applied blue light could protect the deeper ocular structures.
In this work, we wanted to evaluate the antimicrobial effect of riboflavin excitation through exposure of two different wavelengths in the blue light spectrum, in a previously used experimental in vitro model of keratitis.
Materials and Methods
The study adhered to the tenets of the Declaration of Helsinki. A methicillinresistant Staphylococcus aureus (MRSA) reference strain (CCUG41586/ATCC 43300) was withdrawn from frozen (À80°C) vials and cultured two to three times on fresh blood agar plates at +37°C overnight.
Cultured bacteria were counted in a B€ urker chamber and diluted in PBS (GIBCO, no: 14190-094) to approximately 4 9 10 5 /ml. The suspension (10 ll) was mixed with 50 ll of riboflavin (RF) (R 7649-25G; SigmaAldrich, Schnelldorf, Germany) solution in RPMI (GIBCO No: 11835) to a final concentration of 0.01% riboflavin. Controls were combined in the same quantities but without the photosensitizer. The mixture was pipetted (15 ll) onto 7-mm wells on a diagnostic microscope slide (CEL-30-2325BLHTC; Thermo Scientific, Braunschweig, Germany), designed to adhere fluids, creating a fluid layer with a thickness of around 400 microns.
Bacterial suspensions without riboflavin were used as negative control (NegC), on a separate glass slide. These mixtures were also used for controlling the effect of blue light itself (BL) on the same glass as bacteria with riboflavin (RF) solution. The exposed solutions were kept in the wells for the same duration as corresponding controls.
The different bacterial suspensions were exposed to two different doses of approximately 28.5 or 5.4 J/cm 2 of 412/450 nm blue light. The 412 nm light was generated with a commercially available lamp for treatment of acne TRIA Beauty lamp (Mod: SPBL, Acne Clearing Blue Light; Tria Beauty, Inc., Dublin, CA, USA), exposing four samples and four controls on the same glass.
The 450 nm wavelength was conveyed by a prototype lamp (Terumo BCT, Inc., Lakewood, CO, USA). This consisted of three light LEDs (470 nm LED@308.6 mA) with peak at 450 nm (Terumo BCT, Inc.-OL756 scan data) spread on a 5.5-cm line and mounted on top of an aluminium box with a black-coated interior. Exposures using 450 nm were made onto the entire glass (four samples and four controls) simultaneously and the wells containing bacteria with and without RF solution.
Assessment of irradiance (mW/cm 2 ) for illumination devices was made for the relevant distances using a calibrated 308 UV intensity metre (OAI; Optical Associates, Inc., San Jose CA, USA) and calibrated probes (OAI) for 436 and 420 nm.
Different dosages for each wavelength were achieved by altering the distance to slides as well as exposure time. 412 nm: Distance 2.4 cm corresponded to irradiance 47.7 mW/cm 2 (dose = 28.6 J/cm 2 ) and 6.3 cm to 9.0 mW/ cm 2 (dose = 5.4 J/cm 2 ) with exposure time 10 min at both levels. 450 nm: At 9.35 cm distance the irradiance was 47.4 mW/cm 2 , with an exposure time of 10 min (dose = 28.4 J/cm 2 ) and 10.0 mW/cm 2 for 9 min at 21.7 cm distance (dose = 5.4 J/cm 2 ).
Irradiation with high the higher dosages led to noticeable evaporation from the bacterial dilutions, and 5 ll RPMI was added to these wells posttreatment. The mixtures on the negative control glass and glasses with low doses did not need any additional fluid. Experimental exposures/controls were made in four wells and repeated two times on different experimental days, resulting in eight measurements for every experiment.
The 412 nm light effect was also evaluated in a thicker fluid-layer model as used in previous publications (Backman et al. 2014) . Bacterial suspensions were prepared in an identical way as with fluid-film experiments with and without riboflavin; however, 40 ll of the bacterial suspension was placed in sterile corks from Sarstedt laboratory test tubes (no: 72.694.005). These were turned upside down and utilized as wells. As the inner diameter of the cork is 6.6 mm, the fluid forms a layer with a depth of 1.17 mm. Illumination was made using the same settings as specified above. A total of eight measurements were taken on two different days. No additional fluid was added during the course of experiments.
After light exposure of solutions, 5 ll of samples was withdrawn from the experimental wells and diluted in PBS (45 ll). A volume of 25 ll of the mixture originating from each well was spread on a blood agar plate and incubated inverted overnight at +37°C. Colonies were counted with determination of colonyforming unit (CFU) values.
The reduction in CFU was defined as the difference between the blue lightexposed solution (BL) and negative control (NegC) and originated from the same bacterial suspension.
Statistical analysis was performed through unpaired Student's t-test. The software used was SPSS Ò (SPSS Inc. Chicago, IL, USA). p Values below 0.05 were considered statistically significant.
Results
The effect of light exposure with the lower dose without riboflavin was small for both wavelengths, and the changes in CFU were statistically nonsignificant. The presence of riboflavin (RF) during exposure increased the bactericidal effect to 54% (412 nm) and 44% (450 nm), respectively. The differences compared to both nonexposed controls (NegC) and only light-exposed (BL) solutions were statistically significant (p < 0.001). The higher light dose without riboflavin (BL) resulted in a more extensive and statistically significant (p < 0.001) reduction in CFU numbers for both wavelengths (72% for 412 nm and 81% for 450 nm). A nearly complete eradication of pathogens was observed for the higher dosage of light in combination with riboflavin (RF) (99% for 412 nm and 98% for 450 nm) (p < 0.001). The differences between the effect of light with and without riboflavin (BL compared to RF) using the higher dosages were also statistically significant (for 412 nm p < 0.001 and for 450 nm p = 0.002). There were no statistically significant differences in the extent of elimination between the two illumination devices for lower as well as higher dosages (p values ranging between 0.052 and 0.661). In Fig. 1 , the proportion of eradicated bacteria is shown compared to negative controls for both 412 and 450 nm regarding low and high illumination settings.
The evaluation of 412-nm lowdosage irradiation of thicker fluid-layer suspensions resulted in a non-significant inactivation of bacteria without riboflavin (BL) compared to controls (NegC). Riboflavin (RF) solutions during the exposure increased the elimination to 63% (p < 0.001). For the higher dose of blue light exposure, the reduction was 81% without riboflavin (BL) and 93% with the photosensitizer (RF) (p < 0.001). The differences in effect between irradiation with and without riboflavin were statistically significant at both levels (low p < 0.001; high p = 0.004). Figure 2 illustrates the reduction in MRSA for 412 nm wavelength in the 1.14 mm fluid-layer model.
Discussion
In the experiments presented here, we wanted to investigate the antibacterial action of two different wavelengths in the visible blue light spectrum for possible future application in microbial keratitis. Both of the wavelengths evaluated were efficient at eliminating the pathogen studied, with little difference in the outcome. When studying the CFU reduction in 412 nm blue light, the elimination of bacteria was relatively potent, even using low dosage of light, and the addition of riboflavin improved the antimicrobial action of blue light at all studied dosages. The investigation made was limited to MRSA, because the oxidative stress likely mediates a similar antimicrobial effect in different bacterial strains, as have been explored in previous studies (Martins et al. 2008; Schrier et al. 2009; Makdoumi & Backman 2016) . However, a control experiment using a vancomycin-resistant Enterococcus faecalis strain showed similar efficiency as for MRSA, with these treatment dosages (results not shown). As 412 nm has higher energy per photon, it should in theory be more destructive than 450 nm light; however, the latter wavelength corresponds better to the light absorption peak of riboflavin, which is why the biological effect could be a result of more efficient photosensitization..
A low dose (5.4 J) of 412 nm and riboflavin eradicated around 44-55% of MRSA in 400-lm layer used here. This is considerably lower than the same dose UVA with the identical photosensitizer at 5.4 J (89% MRSA eradication) as seen in our recent study (Makdoumi & Backman 2016) . Roughly a five times higher dose (28.4 J) of blue light was required for 98-99% eradication.
The deeper fluid-level (1.17 mm) bactericidal efficiency of 412 nm blue light (28.4 J) and riboflavin was similar or slightly less efficient when matched to previous results for UVA (10.8 J) , in the same experimental design with comparable amounts of bacteria. Nonetheless, riboflavin excitation by a low dose of 412 nm was more efficacious (63% eradication) than the same dose of UVA, where no significant effect on Staphylococcus epidermidis was observed previously (Backman et al. 2014) . If this blue light would be tolerable for the eye, it would seem like a better choice for treating and possibly improve healing of deeper infections.
Blue light can itself be sufficient to generate an antimicrobial effect (Ghate et al. 2016; Fontana et al. 2015; Amin et al. 2016) , but due to the penetration into the eye, the relatively high intensities required and retinotoxic effect of blue light (Kim et al. 2016; Jaadane et al. 2015) , it has limited potential solitarily as a therapeutic in keratitis. As riboflavin has light absorption peaks in this spectrum, some of the light will be absorbed as it passes through the tissue, but due to the higher tissue penetration of visible light compared to ultraviolet light, the risk of endothelial, lens and retinal damage could increase if applied clinically in the cornea. However, in severe cases of corneal infections it may in fact be beneficial to be able to reach the photodynamic effect in deeper corneal layers and in a situation where to avoid an emergency keratoplasty, local endothelial damage may be acceptable.
Photodynamic treatment of clinical corneal infections by way of PACK-CXL is today only possible by way of the excitation of riboflavin using ultraviolet light A, due to the safety profile of the wavelength and the photosensitizer applied (Raiskup et al. 2015; Shalchi et al. 2015) . Although several other molecules have been evaluated, proven efficacious in vitro, and theoretically could be possible to apply in keratitis, several factors need elucidation before clinical application in the eye is realistic (Halili et al. 2016; Wang et al. 2013; Siddiqui & Khan 2012; Nielsen et al. 2015) . Some of these are safety of the compound and chromophore degradation products, tissue transparency after therapy, and minimizing collateral damage with respect to the molecule and light used for excitation. Riboflavin is out of several perspectives an ideal photosensitizer for PACK-CXL because it is already applicable both in vivo in CXL and long documented usage of the molecule in pathogen reduction technology, applied through the Mirasol Ò PRT system (Marschner & Goodrich 2011; Kaiser-Guignard et al. 2014 ). Yet, in clinical cases of keratitis, managed by PACK-CXL deeper ulcers have been seemingly less responsive to the UVAmediated therapy and a limiting factor is plausibly the superficial penetration of 370 nm wavelength (Makdoumi et al. 2012; Sorkhabi et al. 2013; Chan et al. 2015) .
Several experimental studies have explored blue light for scleral crosslinking (SXL) (Zhang et al. 2015; Iseli et al. 2016) , to stop progressive myopization, but we suggest that blue light may also be interesting for the application in corneal infections, because it has deeper tissue penetration and seems potent regarding the elimination of micro-organisms. Although the efficacy of riboflavin excitation by blue light has been questioned previously (Nielsen et al. 2015) , factors such as light dosage, micro-organism evaluated and experimental settings may explain for some divergence in outcomes between earlier studies that have demonstrated its antimicrobial capacity (Liang et al. 2013) .
Antibiotic resistance is an approaching threat to our capability to manage severe infections. It is therefore of importance to continue to explore new alternative therapeutic strategies, and we consider PACK-CXL an interesting approach in corneal infections. Several important aspects will need to be studied before clinical implementation of riboflavin excitation by blue light would be realistic, because data are missing regarding the effect to the corneal tissue and the potential risk of other ocular damage associated with its application. Illumination settings would need to be investigated specifically for the purpose of PACK-CXL and limitations regarding keratocytes, endothelial cells and avoiding the risk of cataract formation as well as retinal damage associated with the irradiation.
In conclusion, the bactericidal effect in MRSA by excitation of riboflavin using blue light is a promising alternative approach to generating the photooxidative stress using ultraviolet light, which merits further evaluation for potential integration in PACK-CXL. More complete data are needed in a wider range of micro-organisms, optimization of irradiation parameters specifically for these wavelengths and to establish the efficacy in vivo compared to UVA-mediated CXL, particularly in deep corneal infiltrates. 
